TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 1628-American Health Care Act; Medicaid Rebate provision of the Bipartisan Budget Act of 2015; draft of the Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; HR 2051-FAST Generics Act; S.637-C-THRU Act; S.771-Improving Access to Affordable Drugs Act; Importation Amdt. to Senate Budget Resolution; S.469-Affordable and Safe Prescription Drug Importation Act; and HR 749-Lower Drugs Through Competition Act.
Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA Inc., has an interest in the issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| DEBRA BARRETT | — |
| SHANNON DZUBIN | — |
| GRANT ERDEL | — |
| ROBERT FALB | — |
Taxation/Internal Revenue Code TAX
Corporate tax reform proposals including proposed board adjustment tax.
Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| SHANNON DZUBIN | — |
| GRANT ERDEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.